SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical Industries informs about company updates

24 Dec 2015 Evaluate

Sun Pharmaceutical Industries has informed that Sun Pharma Laboratories, a wholly-owned subsidiary of the Company, has raised, on Private Placement Basis, Rs. 10,000,000,000 by allotment of 10,000 (ICRA) AAA / Stable Outlook Rated Unsecured Redeemable Non-Convertible Debentures of a face value of Rs 1,000,000 each to be listed on under two series with Series 1 debentures comprising of 5,000 debentures amounting to Rupees Five Hundred Crores with a tenor of 24 months, and Series 2 debentures comprising of 5,000 debentures amounting to Rupees Five Hundred Crores with a tenor of 39 months.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma. Inds. Share Price

1949.90 -4.15 (-0.21%)
24-Jul-2026 10:43 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.90
Dr. Reddys Labs. 1142.95
Cipla 1420.30
Lupin 2358.95
Zydus Lifesciences 1112.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: